Signal de tendance

Évolution des mentions ✨ Nouveau
30j7jMaintenant

10

mentions (7j)

10

mentions (30j)

17 avr. 2026

premier signal

1

pays concernés

Contexte et analyse

Cette tendance "OpenAI's scientific drug-discovery AI model for pharma" a été détectée dans la catégorie Intelligence Artificielle avec un score de 93/100. Cette tendance connaît une croissance explosive et attire beaucoup d'attention actuellement.

Entités liées

https://www.pymnts.com/artificial-intelligence-2/2026/openai-targets-pharma-giants-with-purpose-built-ai-model/https://openai.com/index/introducing-gpt-rosalind/https://endpoints.news/openai-launches-biopharma-focused-ai-model-to-compete-with-anthropic/https://unn.ua/en/news/openai-launches-drug-discovery-model-intensifying-competition-with-googlehttps://www.euronews.com/health/2026/04/14/novo-nordisk-joins-forces-with-openai-to-fast-track-drug-researchhttps://manufacturingchemist.com/novo-nordisk-openai-partner-accelerate-drug-discovery-aihttps://firstwordpharma.com/story/7180278https://www.computerweekly.com/news/366641591/Novo-Nordisk-partners-with-OpenAI-to-AI-power-drug-developmenthttps://www.tradingview.com/news/invezz:df7d47e48094b:0-novo-nordisk-taps-openai-to-boost-ai-in-drug-development/https://www.startuphub.ai/ai-news/artificial-intelligence/2026/openai-unveils-gpt-rosalind-for-science

Extraits des sources

By|April 16, 2026 | ! has introduced an artificial intelligence model that is purpose-built for scientific research and drug discovery. Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required. - [x] yes Subscribe to our daily newsletter, PYMNTS Today. By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordan [Content...

— pymnts.com

Ce que disent les sources

  • "OpenAI introduced an AI model purpose-built for scientific research and drug discovery."

    pymnts.com

  • "Today, we're introducing GPT‑Rosalind, our frontier reasoning model built to support research across biology, drug discovery, and translational medicine."

    openai.com

  • "OpenAI became the latest tech giant to launch a life sciences-focused AI offering, aiming to build a biopharma business."

    endpoints.news

  • "УНН Economy ✎ The new AI model GPT-Rosalind will accelerate scientific research for Amgen and Moderna. Shares of biotechnology companies fell amid the..."

    unn.ua

  • "Danish pharma company Novo Nordisk has announced a partnership with OpenAI to apply artificial intelligence across its drug development process."

    euronews.com

  • "The Wegovy and Ozempic maker has struck a strategic deal with OpenAI to embed artificial intelligence across its entire operations, with full integration..."

    manufacturingchemist.com

  • "Novo Nordisk has become the latest drugmaker to partner with AI heavyweight OpenAI in the hopes that the technology will help it bring new and better..."

    firstwordpharma.com

  • "Danish pharmaceutical company Novo Nordisk has partnered with OpenAI to support drug research and development. Through the partnership, Novo Nordisk said it..."

    computerweekly.com

  • "Novo Nordisk on Tuesday announced a partnership with OpenAI to deploy artificial intelligence across its business, spanning drug discovery,..."

    tradingview.com

  • "OpenAI launches GPT-Rosalind, a specialized AI model designed to accelerate life sciences research and drug discovery workflows."

    startuphub.ai

Partager cette tendance

X LinkedIn